Novo Nordisk A/S

LSE:0TDD Stock Report

Market Cap: US$474.2b

Novo Nordisk Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0TDD?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders146,1850.0033%
Private Companies407,7740.00922%
VC/PE Firms1,258,743,75028.5%
Institutions1,492,280,70833.7%
General Public1,672,741,93937.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 47.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.5%
Novo Holdings A/S
1,258,743,750US$134.9b-0.5%92.92%
5.04%
BlackRock, Inc.
222,953,395US$23.9b0.02%0.38%
2.79%
The Vanguard Group, Inc.
123,527,857US$13.2b0.12%0.19%
1.76%
Norges Bank Investment Management
78,056,581US$8.4b0%0.67%
1.01%
FMR LLC
44,763,831US$4.8b-2.19%0.28%
0.87%
GQG Partners LLC
38,288,480US$4.1b15.9%3.34%
0.67%
Amundi Asset Management SAS
29,852,755US$3.2b13.6%0.65%
0.61%
Jennison Associates LLC
27,138,119US$2.9b1.25%1.58%
0.54%
Geode Capital Management, LLC
24,109,347US$2.6b-1.02%0.18%
0.5%
Deutsche Asset & Wealth Management
22,114,947US$2.4b0%0.66%
0.46%
JP Morgan Asset Management
20,155,929US$2.2b-1%0.23%
0.45%
Alecta Pensionsförsäkring, ömsesidigt
19,933,628US$2.1b0%4.35%
0.41%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
18,297,417US$2.0b-23.1%0.46%
0.38%
T. Rowe Price Group, Inc.
16,656,326US$1.8b-0.01%0.16%
0.37%
Wellington Management Group LLP
16,483,601US$1.8b-0.12%0.28%
0.37%
State Street Global Advisors, Inc.
16,348,107US$1.8b0.64%0.06%
0.36%
Fundsmith, LLP
16,035,654US$1.7b0%5.34%
0.36%
WCM Investment Management, LLC
15,839,764US$1.7b-1.28%2.5%
0.33%
Fisher Asset Management, LLC
14,799,372US$1.6b-0.44%0.62%
0.31%
Handelsbanken Asset Management
13,756,689US$1.5b0.17%2.18%
0.28%
Fayez Sarofim & Co., LLC
12,217,118US$1.3b-2.67%3.27%
0.27%
Capital Research and Management Company
11,899,002US$1.3b-0.05%0.06%
0.27%
UBS Asset Management AG
11,839,800US$1.3b0.82%0.12%
0.26%
Invesco Ltd.
11,535,286US$1.2b0.38%0.32%
0.25%
Massachusetts Financial Services Company
11,095,205US$1.2b1.07%0.25%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 04:03
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Novo Nordisk A/S is covered by 71 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Kamla SinghAlphaValue
Gerhard SchwarzBaader Helvea Equity Research